Physician profile
Brent Hammal Limbaugh
NPI 1285727404
$72,255.85
in general payments reported to CMS, 2019-2025
100 companies · $7,765 in 2025
The $7,765 reported for 2025 was more than what 86% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $17K · 2021: $5,231 · 2022: $5,470 · 2023: $5,053 · 2024: $4,284 · 2025: $7,765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Travel and Lodging: $1,158 · Honoraria: $1,088 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,664.38 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Travel and Lodging | $1,158.28 |
| Honoraria | $1,088.00 |
| Education | $190.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $11,897.40 | 2019-2025 | Lynparza, Calquence, Tagrisso |
| Celgene Corporation | $7,493.06 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Abbvie INC. | $7,099.90 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $5,520.14 | 2019-2024 | Libtayo |
| Incyte Corporation | $3,662.44 | 2019-2024 | Monjuvi, Pemazyre |
| Avyxa Pharma, LLC | $3,338.17 | 2025 | |
| Kite Pharma, INC. | $2,597.25 | 2020-2025 | Yescarta |
| Pfizer INC. | $2,455.49 | 2019-2025 | |
| Seagen INC. | $2,182.89 | 2019-2023 | Tukysa, Adcetris, Tivdak |
| Cti Biopharma Corp. | $2,038.92 | 2022-2023 | Vonjo |
| Novartis Pharmaceuticals Corporation | $1,807.92 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $1,715.58 | 2019-2025 | Keytruda, Lynparza, Welireg |
| E.R. Squibb & Sons, L.L.C. | $1,540.44 | 2019-2025 | Opdivo, Opdualag, Eliquis |
| Blueprint Medicines Corporation | $1,515.84 | 2020-2024 | Ayvakit |
| Janssen Biotech, INC. | $1,329.96 | 2019-2025 | Erleada, Darzalex, Balversa |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $1,187.56 | 2019-2025 | Tecentriq, Avastin, Rozlytrek |
| Genzyme Corporation | $1,168.75 | 2019-2025 | |
| Coherus Oncology, INC. | $1,139.47 | 2022-2023 | |
| Daiichi Sankyo INC. | $883.45 | 2019-2025 | Enhertu, Injectafer, Datroway |
| Gilead Sciences, INC. | $660.01 | 2021-2025 | Trodelvy |
| Novocure INC. | $524.00 | 2019 | |
| Glaxosmithkline, LLC. | $512.31 | 2020-2025 | Jemperli, Zejula, Ojjaara |
| Taiho Oncology, INC. | $508.84 | 2020-2025 | |
| Astellas Pharma US INC | $507.05 | 2019-2025 | Xtandi, Vyloy, Xospata |
| Exelixis INC. | $481.31 | 2020-2025 | Cabometyx |
| Beigene, Ltd. | $450.00 | 2020 | |
| Eisai INC. | $430.94 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $429.29 | 2019-2025 | |
| Puma Biotechnology, INC. | $419.65 | 2019-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $368.23 | 2019-2023 | Imbruvica, Epkinly |
| Octapharma USA, INC. | $363.33 | 2020-2024 | Octagam Immune Globulin (Human) |
| Stemline Therapeutics INC. | $313.92 | 2023-2025 | Orserdu, Elzonris |
| Array Biopharma INC | $280.15 | 2019-2025 | Braftovi, Mektovi, Lorbrena |
| Takeda Pharmaceuticals U.S.A., INC. | $274.53 | 2019-2025 | Fruzaqla, Ninlaro |
| Alexion Pharmaceuticals, INC. | $257.73 | 2019-2025 | Ultomiris |
| Boehringer Ingelheim Pharmaceuticals, INC. | $237.67 | 2019-2024 | Gilotrif |
| Jazz Pharmaceuticals INC. | $234.04 | 2020-2025 | |
| Beigene USA, INC. | $229.69 | 2020-2024 | Brukinsa, Tevimbra |
| Emd Serono, INC. | $224.10 | 2019-2025 | Tepmetko |
| Aveo Pharmaceuticals, INC. | $223.07 | 2021-2025 | Fotivda |
| Lilly USA, LLC | $222.15 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Karyopharm Therapeutics INC. | $171.37 | 2020-2024 | Xpovio |
| Acrotech Biopharma INC. | $171.18 | 2021-2025 | Beleodaq |
| Athenex Pharmaceutical Division, LLC | $150.00 | 2020 | |
| Tersera Therapeutics LLC | $140.82 | 2019-2025 | Quzyttir |
| Sumitomo Pharma America, INC. | $138.60 | 2023-2025 | Orgovyx, Gemtesa |
| Beone Medicines USA, INC. | $136.08 | 2025 | Brukinsa |
| Deciphera Pharmaceuticals INC. | $127.22 | 2022-2024 | Qinlock, Tgct |
| Ipsen Biopharmaceuticals, INC | $123.29 | 2019-2024 | Onivyde, Somatuline Depot |
| Boston Scientific Corporation | $121.04 | 2022-2025 | Solyx Sis System |
| Genmab U.S., INC. | $112.21 | 2023-2025 | Epkinly |
| Iovance Biotherapeutics, INC. | $105.66 | 2025 | Amtagvi |
| Dendreon Pharmaceuticals LLC | $105.43 | 2020-2024 | Provenge |
| Adaptive Biotechnologies Corporation | $102.01 | 2021-2023 | Clonoseq |
| Rigel Pharmaceuticals, INC. | $96.48 | 2021-2024 | Rezlidhia, Tavalisse |
| Sun Pharmaceutical Industries INC. | $91.47 | 2019-2025 | Odomzo, Yonsa |
| Myovant Sciences INC. | $90.56 | 2021-2022 | |
| G1 Therapeutics, INC. | $89.03 | 2022-2023 | Cosela |
| Kyowa Kirin, INC. | $67.56 | 2019-2021 | |
| Azurity Pharmaceuticals, INC. | $58.87 | 2025 | Danziten |
| Heron Therapeutics, INC. | $58.04 | 2019-2023 | Cinvanti |
| Foundation Medicine, INC. | $57.71 | 2023 | Foundationone Cdx |
| Verastem, INC. | $57.43 | 2019-2020 | |
| Spectrum Pharmaceuticals INC. | $56.57 | 2019-2025 | Rolvedon |
| Recordati_rare_diseases_inc. | $55.33 | 2023-2025 | Sylvant |
| Adc Therapeutics America, INC. | $54.92 | 2022-2025 | |
| Clovis Oncology, INC. | $49.76 | 2019-2020 | |
| Pharmacosmos Therapeutics INC. | $49.27 | 2020-2025 | Monoferric |
| Sobi, INC | $48.18 | 2022-2025 | |
| Aurobindo Pharma USA, INC. | $47.89 | 2019-2020 | |
| Amgen INC. | $44.25 | 2020-2023 | Kyprolis, Nplate, Xgeva |
| Sanofi-Aventis U.S. LLC | $42.02 | 2020 | |
| Agios Pharmaceuticals, INC. | $40.09 | 2020-2024 | Pyrukynd |
| Verity Pharmaceuticals INC. | $38.67 | 2025 | Trelstar |
| Amag Pharmaceuticals, INC. | $38.36 | 2019-2021 | |
| Springworks Therapeutics, INC. | $37.60 | 2024-2025 | Ogsiveo |
| Mylan Institutional INC. | $35.20 | 2021-2022 | |
| Geron Corporation | $34.85 | 2025 | Rytelo |
| Shire North American Group INC | $33.88 | 2019 | |
| Eusa Pharma (US) LLC | $32.71 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $29.45 | 2024 | Aria Radiation Therapy Management Software |
| Fennec Pharmaceuticals, INC. | $27.97 | 2024 | Pedmark |
| Epizyme, INC. | $27.86 | 2021-2022 | |
| Helsinn Therapeutics (U.S.), INC. | $26.93 | 2019 | |
| Pharmaand Gmbh | $24.36 | 2025 | Rubraca |
| Tolmar, INC. | $24.36 | 2025 | Rubraca, Eligard |
| Tempus Ai, INC | $23.40 | 2025 | Xt Cdx |
| Secura Bio, INC. | $20.25 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $20.06 | 2020 | |
| Sirtex Medical INC | $19.65 | 2019 | |
| Immunocore Limited | $19.02 | 2025 | Kimmtrak |
| Partner Therapeutics, INC. | $17.89 | 2019 | |
| Legend Biotech USA INC. | $16.66 | 2025 | Carvykti |
| Organogenesis INC. | $15.93 | 2024 | Puraply Franchise |
| Servier Pharmaceuticals LLC | $15.92 | 2023 | |
| Pharmaessentia USA Corporation | $15.59 | 2024 | Besremi |
| Morphosys, US INC. | $13.89 | 2022 | |
| Tg Therapeutics, INC. | $13.33 | 2023 | |
| Janssen Pharmaceuticals, INC | $13.11 | 2019 | |
| Dova Pharmaceuticals | $12.47 | 2021 |
Drugs and devices associated with these payments
Keytruda $753Enhertu $433Lynparza $385Kisqali $372Opdivo $322Scemblix $319Brukinsa $309Imbruvica $302Tukysa $266Nubeqa $261Opdualag $244Orserdu $235Trodelvy $234Braftovi $231Tecentriq $231Lonsurf $226Inqovi $226Xtandi $224Libtayo $212Mektovi $202Orgovyx $201Xofigo $185Avastin $185Rozlytrek $185Alecensa $185Injectafer $180Cabometyx $174Calquence $168Fotivda $163Venclexta $159Fabhalta $155Ultomiris $155Lenvima $154Tagrisso $147Zepzelca $143Ibrance $134Welireg $133Epkinly $131Erleada $129Lorbrena $127Yescarta $127Talzenna $122Beleodaq $122Fruzaqla $120Polivy $119Adcetris $118Darzalex $116Zejula $115Jemperli $115Gavreto $112Qinlock $111Piqray $111Sarclisa $110Verzenio $110Jaypirca $110Amtagvi $106Reblozyl $98.30Padcev $91.52Pomalyst $91.51Elrexfio $89.58Provenge $87.74Elzonris $79.39Lunsumio $77.73Ojjaara $76.43Odomzo $76.17Comirnaty $75.84Paxlovid $74.39Balversa $73.72Bosulif $70.48Nerlynx $69.11Gilotrif $68.86Retevmo $67.81Datroway $65.41Onivyde $65.00Vyloy $62.82Emrelis $61.98Jevtana $60.93Columvi $60.69Tecvayli $60.14Phesgo $59.18Danziten $58.87Inlyta $55.77Xpovio $55.60Sylvant $55.33Ninlaro $54.07Monjuvi $53.49Pemazyre $53.49Xalkori $52.75Yonsa $52.31Promacta $50.82Tavalisse $50.24Rezlidhia $50.24Besponsa $49.89Akeega $48.83Rubraca $48.72Talvey $40.73Trelstar $38.67Quzyttir $38.13Vonjo $37.72Ogsiveo $37.60
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Limbaugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.